Figure 28.1
H&E 100× paracoccidiomycosis, a dense infiltrate of histocytes
Figure 28.2
H&E 1,000×, note central yeast-like organisms with small daughter yeasts at the peripheral rim
Serological tests are available but not used as they are rarely diagnostic. HIV testing may be performed in patients suspected of infection. Chest radiography should always be performed to check for pulmonary involvement.
Treatment
The first line treatment for moderate cases of infection is itraconazole 100 mg daily for 6 months If that therapy fails, ketoconazole 400 mg daily for 6–18 months may be used. In severe cases of infection or in cases with meningeal involvement, IV amphotericin B 0.4–0.5 mg/kg is recommended daily until a total dose of 1.5–2.5 mg/kg has been administered.
Prevention
When traveling, it is recommended that endemic regions be avoided. Disease presentation can be delayed with cases reported 60 days after initial infection. Early detection and diagnosis is important to prevent disseminated disease, permanent disfigurement and death. Whenever the combination of pulmonary, cutaneous, mucosal, and lymphatic involvement is observed, paracoccidioidomycosis should be at the top of the differential diagnoses list.
Recommended Reading